Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Pacifici

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Clinical Pharmacokinetics|May 25, 2005
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probeMireia Segura, Magí Farré, Simona Pichini, et al.
Phytotherapy Research : PTR|November 6, 2020
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabisAna P Pérez-Acevedo, Roberta Pacifici, Giulio Mannocchi, et al.
Talanta|December 10, 2020
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabisSimona Pichini, Sara Malaca, Massimo Gottardi, et al.
Pharmaceuticals (Basel, Switzerland)|January 16, 2021
Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical CannabisFrancesco Paolo Busardò, Ana Pilar Pérez-Acevedo, Roberta Pacifici, et al.
European Journal of Public Health|July 17, 2018
A long way to go: 20-year trends from multiple surveillance systems show a still huge use of tobacco in minors in ItalyGiuseppe Gorini, Silvano Gallus, Giulia Carreras, et al.
Biology|April 3, 2021
Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational UsersNunzia La Maida, Esther Papaseit, Lucia Martínez, et al.
Biology|May 28, 2022
New Psychoactive Substances Consumption in Opioid-Use Disorder PatientsMaria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD FormulationsSara Malaca, Massimo Gottardi, Federica Pigliasco, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2009
Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletesRosario Abellan, Rosa Ventura, Ilaria Palmi, et al.
Frontiers in Psychiatry|August 22, 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patientsMaría Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Clinical Pharmacokinetics|May 25, 2005
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probeMireia Segura, Magí Farré, Simona Pichini, et al.
Phytotherapy Research : PTR|November 6, 2020
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabisAna P Pérez-Acevedo, Roberta Pacifici, Giulio Mannocchi, et al.
Talanta|December 10, 2020
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabisSimona Pichini, Sara Malaca, Massimo Gottardi, et al.
Pharmaceuticals (Basel, Switzerland)|January 16, 2021
Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical CannabisFrancesco Paolo Busardò, Ana Pilar Pérez-Acevedo, Roberta Pacifici, et al.
European Journal of Public Health|July 17, 2018
A long way to go: 20-year trends from multiple surveillance systems show a still huge use of tobacco in minors in ItalyGiuseppe Gorini, Silvano Gallus, Giulia Carreras, et al.
Biology|April 3, 2021
Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational UsersNunzia La Maida, Esther Papaseit, Lucia Martínez, et al.
Biology|May 28, 2022
New Psychoactive Substances Consumption in Opioid-Use Disorder PatientsMaria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD FormulationsSara Malaca, Massimo Gottardi, Federica Pigliasco, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2009
Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletesRosario Abellan, Rosa Ventura, Ilaria Palmi, et al.
Frontiers in Psychiatry|August 22, 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patientsMaría Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Pageof 22